← back to search

Rolf Fimmers

Institute for Research Information and Quality Assurance ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Forensic and Genetic Research, Molecular Biology Techniques and Applications, and Retinal Diseases and Treatments.
h-index
79
citations
21,581
works
472
NIH funding
primary concept
email

Recent publications

PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial
Trials 2022cited by 17position: middledoi
Flapless application of enamel matrix derivative in periodontal retreatment: A multicentre randomized feasibility trial
Journal Of Clinical Periodontology 2021cited by 29position: middledoi
Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration
Investigative Ophthalmology & Visual Science 2020cited by 41position: middledoi
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
The Lancet 2019cited by 572position: middledoi
Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival
Clinical Gastroenterology and Hepatology 2019cited by 105position: middledoi
Olfactory function as an independent prognostic factor in glioblastoma
Neurology 2019cited by 11position: middledoi
Effect of alpha-linolenic acid in combination with the flavonol quercetin on markers of cardiovascular disease risk in healthy, non-obese adults: A randomized, double-blinded placebo-controlled crossover trial
Nutrition 2018cited by 40position: middledoi
ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial
Neuro-Oncology 2017cited by 22position: middledoi
Effects of the flavonol quercetin and<i>α</i>-linolenic acid on<i>n</i>-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial
British Journal Of Nutrition 2017cited by 19position: middledoi
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
Clinical Cancer Research 2016cited by 72position: middledoi
No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial
European Journal of Nutrition 2016cited by 56position: middledoi
Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial
European Journal of Nutrition 2016cited by 47position: middledoi
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Journal of Cancer Research and Clinical Oncology 2016cited by 34position: middledoi
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
Gastroenterology 2015cited by 253position: lastdoi
Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial
British Journal Of Nutrition 2015cited by 229position: middledoi
Expression of antimicrobial peptides and interleukin‐8 during early stages of inflammation: An experimental gingivitis study
Journal of Periodontal Research 2015cited by 32position: middledoi
TIPS oder hämodynamisch kontrollierte konservative Therapie zur Verhinderung der Ösophagusvarizenrezidivblutung?
Zeitschrift für Gastroenterologie 2014cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2015–2018) · 5 papers (2015–2018) · 5 papers (2015–2018)Peter Langguth · Johannes Gutenberg University Mainz5 papers (2015–2018) · 5 papers (2015–2018) · 5 papers (2015–2018) · 3 papers (2015–2016) · 3 papers (2015–2016) · 3 papers (2015–2016)Georg Nickenig · Hospital Clínico San Carlos3 papers (2015–2016) · 3 papers (2014–2019)Tilman Sauerbruch · Goethe University Frankfurt3 papers (2014–2019)Jonel Trebicka · Nordic Bioscience (Denmark)3 papers (2014–2019)Alexander Zipprich · Klinikum Magdeburg2 papers (2014–2015) · 2 papers (2014–2015)Björn Scheffler · German Cancer Research Center2 papers (2016–2019) · 2 papers (2015–2021)Ulrich Herrlinger · Brain (Germany)2 papers (2016–2019)Albrecht Hoffmeister · University Hospital Heidelberg2 papers (2014–2015) · 2 papers (2016–2022)